Loading clinical trials...

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01241331

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.

Lead sponsor: Braintree Laboratories•20 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

NCT07205107 · Acne Vulgaris

RECRUITINGEARLY Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

NCT06225570 · Acne Vulgaris

RECRUITINGPhase 1/2

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

NCT05891795 · Acne Vulgaris

RECRUITINGNA

Vitamin D Supplementation in Acne

NCT06141330 · Acne Vulgaris

RECRUITINGNA

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

NCT06501560 · Acne Vulgaris

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment233

Start dateNov 2010

Last updatedOct 1, 2012

Condition

Acne Vulgaris

Locations shown

Center for Dermatology Clincal Research

Fremont, California

Dermatology Research Associates

Los Angeles, California

Dermatology Specialists

Oceanside, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2012Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions